AccuBoost announces Hypofractionated Accelerated Partial Breast Irradiation (APBI) trial for Non-Invasive Breast Brachytherapy (NIBB)
Advanced Radiation Therapy, creators of the AccuBoost Breast Brachytherapy technology, is pleased to announce that the Brown University Oncology Research Group (BrUOG) has launched a new multicenter NIBB APBI clinical trial based on the results of its previous study. The new study, FAST APBI (ref BrUOG 291), will deliver 28.5 Gy in 5 fractions compared to 34 Gy in 10 fractions from the previous trial (ref BrUOG 251). Dr. Jarek Hepel of Rhode Island Hospital is the Principal Investigator of both trials. The Watson Clinic of Lakeland, FL is also participating in this trial with potential additional sites to be added in the future. The implications of being able to shorten the course of therapy has far-reaching implications both from the standpoint of patient convenience as well as overall treatment cost.
Ray Bricault, COO of Advanced Radiation Therapy commented “We are very pleased to see the continued interest in the use of AccuBoost for non-invasive APBI particularly in light of the very positive initial results.as well as the potential benefits to patients.”
For more information on AccuBoost, and how typical treatments utilizing the AccuBoost applicators are performed, please visit AccuBoost’s recently updated website https://www.accuboost.com. For more information on the clinical trial, please visit http://clinicaltrials.gov/show/NCT01961531 or contact the Department of Radiation Oncology at Rhode Island Hospital.